Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy

समान संसाधन

• Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia
  द्वारा: Al-Kali, Aref, और अन्य
  प्रकाशित: (2010)
• Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy
  द्वारा: Pemmaraju, Naveen, और अन्य
  प्रकाशित: (2012)
• Outcome After Failure of Second Generation Tyrosine Kinase Inhibitors Treatment As First-line Therapy for Patients With Chronic Myeloid Leukemia
  द्वारा: Eghtedar, Alireza, और अन्य
  प्रकाशित: (2013)
• Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies
  द्वारा: Verma, Dushyant, और अन्य
  प्रकाशित: (2011)
• Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities
  द्वारा: Jain, Preetesh, और अन्य
  प्रकाशित: (2013)